Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes

Clinical Lung Cancer

Volumn 14, Issue 6, 2013, Pages

  Skrzypski, Marcin ^a   Dziadziuszko, Rafał ^a   Jassem, Ewa ^a   Szymanowska Narloch, Amelia ^a   Gulida, Grazyna ^a   Rzepko, Robert ^a   Biernat, Wojciech ^a   Taron, Miquel ^b   Jelitto Górska, Małgorzata ^a   Marjański, Tomasz ^a   Rzyman, Witold ^a   Rosell, Rafael ^b   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Adjuvant chemotherapy; Gene expression; Lung adenocarcinoma; Prognosis; Reverse transcriptase polymerase chain reaction; Squamous cell lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CA9 GENE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; CSF1 GENE; DUSP6 GENE; EGFR GENE; ERBB3 GENE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LCK GENE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MMD GENE; ONCOGENE; OUTCOME ASSESSMENT; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAT1 GENE;

ADJUVANT CHEMOTHERAPY; GENE EXPRESSION; LUNG ADENOCARCINOMA; PROGNOSIS; REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION; SQUAMOUS CELL LUNG CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DUAL SPECIFICITY PHOSPHATASE 6; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOKINES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; STAT1 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84887216854     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.04.010     Document Type: Article

References (46)

1. J. Pignon, H. Tribodet, and G. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
2. D.A. Wigle, I. Jurisica, and N. Radulovich Molecular profiling of non-small cell lung cancer and correlation with disease-free survival Cancer Res 62 2002 3005 3008
3. H. Chen, S. Yu, and C. Chen A five-gene signature and clinical outcome in non-small-cell lung cancer N Engl J Med 356 2007 11 20
4. S. Lau, P. Boutros, and M. Pintilie Three-gene prognostic classifier for early-stage non small-cell lung cancer J Clin Oncol 25 2007 5562 5569
5. P. Roepman, J. Jassem, and E.F. Smit An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer Clin Cancer Res 15 2009 284 290
6. N. Guo, Y. Wan, and K. Tosun Confirmation of gene expression-based prediction of survival in non-small cell lung cancer Clin Cancer Res 14 2008 8213 8220
7. C. Zhu, K. Ding, and D. Strumpf Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer J Clin Oncol 28 2010 4417 4424
8. G. Scagliotti, T. Brodowicz, and F.A. Shepherd Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer J Thorac Oncol 6 2011 64 70
9. D. Raz, M. Ray, and J. Kim A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma Clin Cancer Res 14 2008 5565 5570
10. M. Skrzypski, E. Jassem, and M. Taron Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung Clin Cancer Res 14 2008 4794 4799
11. M. Raponi, Y. Zhang, and J. Yu Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung Cancer Res 66 2006 7466 7472
12. K. Shedden, J. Taylor, and S. Enkemann Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nat Med 14 2008 822 827
13. R. Rosell, T. Moran, and C. Queralt Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 2009 958 967
14. V. Monica, G.V. Scagliotti, and P. Ceppi Differential thymidylate synthase expression in different variants of large-cell carcinoma of the lung Clin Cancer Res 15 2009 7547 7552
15. P. Ceppi, M. Volante, and S. Saviozzi Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase Cancer 107 2006 1589 1596
16. A. Bhattacharjee, W. Richards, and J. Staunton Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc Natl Acad Sci U S A 98 2001 13790 13795
17. S. Saviozzi, F. Cordero, and M. Lo Iacono Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer BMC Cancer 6 2006 200
18. L. Su, C. Chang, and Y. Wu Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme BMC Genomics 8 2007 140
19. K. Livak, and T. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
20. J. Vandesompele, K. De Preter, and F. Pattyn Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
21. G. Sithanandam, and L.M. Anderson The ERBB3 receptor in cancer and cancer gene therapy Cancer Gene Ther 15 2008 413 448
22. H. Nakamura, N. Kawasaki, and M. Taguchi Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis Thorax 61 2006 140 145
23. K. Okudela, T. Yazawa, and T. Woo Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis Am J Pathol 175 2009 867 881
24. Z. Zhang, S. Kobayashi, and A.C. Borczuk Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells Carcinogenesis 31 2010 577 586
25. J.B. Wyckoff, Y. Wang, and E.Y. Lin Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors Cancer Res 67 2007 2649 2656
26. J. Wyckoff, W. Wang, and E.Y. Lin A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors Cancer Res 64 2004 7022 7029
27. J.J. Chen, Y.C. Lin, and P.L. Yao Tumor-associated macrophages: the double-edged sword in cancer progression J Clin Oncol 23 2005 953 964
28. X.D. Zhu, J.B. Zhang, and P.Y. Zhuang High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma J Clin Oncol 26 2008 2707 2716
29. E. Richardsen, R.D. Uglehus, and J. Due The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma Histopathology 53 2008 30 38
30. B. Elsberger, R. Fullerton, and S. Zino Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression Br J Cancer 103 2010 899 909
31. T. Watanabe, T. Kobunai, and Y. Yamamoto Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes Eur J Cancer 46 2010 2119 2126
32. J.R. Kratz, J. He, and S.K. Van Den Eeden A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies Lancet 379 2012 823 832
33. P. Chu, J. Pardo, and H. Zhao Systematic identification of regulatory proteins critical for T-cell activation J Biol 2 2003 21
34. Y. Su, E.K. Jackson, and E. Gorelik Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes Cancer Immunol Immunother 60 2010 111 122
35. Y.T. Tang, T. Hu, and M. Arterburn PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif J Mol Evol 61 2005 372 380
36. M. Ilie, N. Mazure, and V. Hofman High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer Br J Cancer 102 2010 1627 1635
37. J.J. Patard, P. Fergelot, and P.I. Karakiewicz Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma Int J Cancer 123 2008 395 400
38. A.B. Stillebroer, P.F. Mulders, and O.C. Boerman Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy Eur Urol 58 2010 75 83
39. G. Li, G. Feng, and A. Gentil-Perret CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy Clin Exp Metastasis 24 2007 149 155
40. D.E. Swinson, J.L. Jones, and D. Richardson Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer J Clin Oncol 21 2003 473 482
41. M. Ilie, V. Hofman, and C. Ortholan Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis Int J Cancer 128 2010 1614 1623
42. Y. Wang, X.Y. Wang, and J.R. Subjeck Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant Mol Cancer Ther 7 2008 3867 3877
43. Y. Wang, X.Y. Wang, and J.R. Subjeck Covalent crosslinking of tumor antigens stimulates an antitumor immune response Vaccine 28 2010 6613 6620
44. N.N. Khodarev, P. Roach, and S.P. Pitroda STAT1 pathway mediates amplification of metastatic potential and resistance to therapy PLoS One 4 2009 e5821
45. J. Li, B. Yu, and L. Song Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cells J Interferon Cytokine Res 27 2007 209 220
46. R. Chari, K.M. Lonergan, and L.A. Pikor A sequence-based approach to identify reference genes for gene expression analysis BMC Med Genomics 3 2010 32